News

Keeping you current on new and follow-on investments, portfolio product and service milestones, publications and events, management and board transitions, and other developments in Tullis funds.

May

11

Exagen Inc. Reports First Quarter 2026 Results

Delivers record total revenue and AVISE® CTD average selling price CARLSBAD, Calif., May 11, 2026 (GLOBE...

27

Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026

Conference call at 8:30 a.m. ET (5:30 a.m. PT) CARLSBAD, Calif., April 27, 2026 (GLOBE NEWSWIRE) — Exagen...

12

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD

The milestone demonstrates AVISE CTD’s value and adoption within the rheumatologic community, clearly demonstrating...

Recent developments

May

11

Exagen Inc. Reports First Quarter 2026 Results

April

27

Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026

December

12

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD